Book contents
- Frontmatter
- Contents
- Acknowledgements
- Introduction
- 1 Hyperglycaemia
- 2 Hypoglycaemia
- 3 Management of hyperinsulinism
- 4 Hypoglycaemia in infant of a diabetic mother
- 5 Dysmorphic features
- 6 Micropenis
- 7 Hypopituitarism
- 8 Ambiguous genitalia (male): XY disorders of sex development
- 9 Cryptorchidism
- 10 Ambiguous genitalia (female): XX disorders of sex development
- 11 Pigmented scrotum
- 12 Adrenal failure
- 13 Collapse
- 14 Hypotension
- 15 Hyponatraemia
- 16 Hyperkalaemia
- 17 Hypernatraemia
- 18 Maternal steroid excess
- 19 Hypercalcaemia
- 20 Hypocalcaemia
- 21 Investigation and management of babies of mothers with thyroid disease
- 22 Maternal or familial thyroid disease
- 23 Goitre
- 24 Abnormal neonatal thyroid function tests
- 25 Hypothyroxinaemia in preterm infants
- Appendix 1 Calculation of glucose infusion rate
- Appendix 2 Dynamic tests
- Appendix 3 Normal ranges
- Appendix 4 Biochemistry samples
- Appendix 5 Formulary
- Index
1 - Hyperglycaemia
Published online by Cambridge University Press: 15 February 2010
- Frontmatter
- Contents
- Acknowledgements
- Introduction
- 1 Hyperglycaemia
- 2 Hypoglycaemia
- 3 Management of hyperinsulinism
- 4 Hypoglycaemia in infant of a diabetic mother
- 5 Dysmorphic features
- 6 Micropenis
- 7 Hypopituitarism
- 8 Ambiguous genitalia (male): XY disorders of sex development
- 9 Cryptorchidism
- 10 Ambiguous genitalia (female): XX disorders of sex development
- 11 Pigmented scrotum
- 12 Adrenal failure
- 13 Collapse
- 14 Hypotension
- 15 Hyponatraemia
- 16 Hyperkalaemia
- 17 Hypernatraemia
- 18 Maternal steroid excess
- 19 Hypercalcaemia
- 20 Hypocalcaemia
- 21 Investigation and management of babies of mothers with thyroid disease
- 22 Maternal or familial thyroid disease
- 23 Goitre
- 24 Abnormal neonatal thyroid function tests
- 25 Hypothyroxinaemia in preterm infants
- Appendix 1 Calculation of glucose infusion rate
- Appendix 2 Dynamic tests
- Appendix 3 Normal ranges
- Appendix 4 Biochemistry samples
- Appendix 5 Formulary
- Index
Summary
Clinical presentation
Hyperglycaemia is usually picked up incidentally on routine blood glucose assessment or in response to finding glycosuria.
It may be noted as part of the workup of a sick baby.
Definition of hyperglycaemia
The upper end of the ‘normal’ range for blood sugar has not been clearly defined in neonatal practice, although levels of >7 mmol/L are unusual in healthy term babies. Most neonatologists would treat by reducing sugar intake or with insulin if the blood sugar is >10–12 mmol/L, especially if there is significant glycosuria causing an osmotic diuresis, particularly in sick preterm babies. However, tighter glucose control in intensive care patients may be more appropriate.
Approach to the problem
Hyperglycaemia usually occurs in very preterm or small-for-gestational age (SGA) babies due to impaired insulin secretion and/or insulin resistance as well as immaturity of the liver enzymes involved in glucose metabolism (dysregulation of glucose homeostasis).
If hyperglycaemia occurs out of context (such as a previously healthy appropriate-for-gestational-age, enterally fed infant), the cause needs to be identified.
Differential diagnosis
Commonly
Iatrogenic from excessive intravenous glucose delivery
Impaired glucose homeostasis in preterm/SGA baby
Sepsis
Stress
Drugs particularly corticosteroids
Rarely
Transient neonatal diabetes
Permanent neonatal diabetes
Pancreatic agenesis
Investigations
Measure the true blood glucose to confirm the diagnosis.
Calculate the glucose infusion rate (see Appendix 1) to exclude excessive glucose delivery.
- Type
- Chapter
- Information
- Practical Neonatal Endocrinology , pp. 1 - 6Publisher: Cambridge University PressPrint publication year: 2006